In aged mice subjected to ischemic stroke, adropin markedly decreased infarct volume and brain edema and improved both sensorimotor and cognitive functions, with effects linked to reduced MMP-9 activity and preservation of tight junction proteins [163]. The gene discussed is MMP9; the disease is ischemic stroke.